Trial Profile
Clinical Trial to Evaluate the Safety and Efficacy for Wound Healing of Boulinum Toxin Type A in Patients with Lacerated Wound
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Sep 2019
Price :
$35
*
At a glance
- Drugs Letibotulinumtoxina (Primary)
- Indications Scars
- Focus Therapeutic Use
- 01 Aug 2019 Results published in the Medicine.
- 19 Jun 2018 New trial record